Literature DB >> 11983809

The leptin defense against wasting is abolished in the IL-2-deficient mouse model of inflammatory bowel disease.

Lisa M Gaetke1, Helieh S Oz, Willem J S de Villiers, Gary W Varilek, Robert C Frederich.   

Abstract

Anorexia is a major complication of inflammatory bowel disease (IBD). We postulated that chronic intestinal inflammation with increased proinflammatory cytokines elevates serum leptin concentration, thereby contributing to anorexia. This hypothesis was studied in interleukin-2-deficient (IL-2(-/-)) mice, a model of IBD with elevated proinflammatory cytokine production. IL-2(-/-), wild-type pair-fed and wild-type control male mice (8 wk old) were fed regular laboratory mouse food for 2 wk. The IL-2(-/-) and pair-fed groups consumed less food and lost weight. Serum leptin concentrations in the IL-2(-/-) mice in the fed state were lower than controls, but not different from pair-fed mice, and paradoxically increased in the starved state to levels significantly higher than both starved control and pair-fed groups. This result did not change when serum leptin was adjusted for amount of body fat. These data show abnormal leptin responses in IL-2(-/-) mice with increased leptin concentrations disproportionate to fat mass and prevention of the normal decline in leptin with food restriction.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11983809     DOI: 10.1093/jn/132.5.893

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  10 in total

1.  miR-155 deficiency protects mice from experimental colitis by reducing T helper type 1/type 17 responses.

Authors:  Udai P Singh; Angela E Murphy; Reilly T Enos; Haidar A Shamran; Narendra P Singh; Honbing Guan; Venkatesh L Hegde; Daping Fan; Robert L Price; Dennis D Taub; Manoj K Mishra; Mitzi Nagarkatti; Prakash S Nagarkatti
Journal:  Immunology       Date:  2014-11       Impact factor: 7.397

2.  Bacillus polyfermenticus ameliorates colonic inflammation by promoting cytoprotective effects in colitic mice.

Authors:  Eunok Im; Yoon Jeong Choi; Charalabos Pothoulakis; Sang Hoon Rhee
Journal:  J Nutr       Date:  2009-08-12       Impact factor: 4.798

3.  Chemokine and cytokine levels in inflammatory bowel disease patients.

Authors:  Udai P Singh; Narendra P Singh; E Angela Murphy; Robert L Price; Raja Fayad; Mitzi Nagarkatti; Prakash S Nagarkatti
Journal:  Cytokine       Date:  2015-10-29       Impact factor: 3.861

4.  Leptin antagonist ameliorates chronic colitis in IL-10⁻/⁻ mice.

Authors:  Udai P Singh; Narendra P Singh; Hongbing Guan; Brandon Busbee; Robert L Price; Dennis D Taub; Manoj K Mishra; Raja Fayad; Mitzi Nagarkatti; Prakash S Nagarkatti
Journal:  Immunobiology       Date:  2013-05-13       Impact factor: 3.144

Review 5.  The emerging role of leptin antagonist as potential therapeutic option for inflammatory bowel disease.

Authors:  Udai P Singh; Narendra P Singh; Hongbing Guan; Brandon Busbee; Robert L Price; Dennis D Taub; Manoj K Mishra; Raja Fayad; Mitzi Nagarkatti; Prakash S Nagarkatti
Journal:  Int Rev Immunol       Date:  2013-07-10       Impact factor: 5.311

6.  Leptin increase in multiple sclerosis associates with reduced number of CD4(+)CD25+ regulatory T cells.

Authors:  Giuseppe Matarese; Pietro Biagio Carrieri; Antonio La Cava; Francesco Perna; Veronica Sanna; Veronica De Rosa; Daniela Aufiero; Silvia Fontana; Serafino Zappacosta
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-23       Impact factor: 11.205

Review 7.  Unraveling the link between leptin, ghrelin and different types of colitis.

Authors:  Elisavet K Tiaka; Anastassios C Manolakis; Andreas N Kapsoritakis; Spyros P Potamianos
Journal:  Ann Gastroenterol       Date:  2011

Review 8.  Adipokines and the role of visceral adipose tissue in inflammatory bowel disease.

Authors:  Thomas Karrasch; Andreas Schaeffler
Journal:  Ann Gastroenterol       Date:  2016-09-06

9.  Genistein induces macrophage polarization and systemic cytokine to ameliorate experimental colitis.

Authors:  Jessicca D Abron; Narendra P Singh; Robert L Price; Mitzi Nagarkatti; Prakash S Nagarkatti; Udai P Singh
Journal:  PLoS One       Date:  2018-07-19       Impact factor: 3.752

10.  Green Tea Polyphenols and Sulfasalazine have Parallel Anti-Inflammatory Properties in Colitis Models.

Authors:  Helieh S Oz; Theresa Chen; Willem J S de Villiers
Journal:  Front Immunol       Date:  2013-06-05       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.